Cargando…
Advances with Lipid-Based Nanosystems for siRNA Delivery to Breast Cancers
Breast cancer is the most frequently diagnosed cancer among women. Breast cancer is also the key reason for worldwide cancer-related deaths among women. The application of small interfering RNA (siRNA)-based drugs to combat breast cancer requires effective gene silencing in tumor cells. To overcome...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386415/ https://www.ncbi.nlm.nih.gov/pubmed/37513882 http://dx.doi.org/10.3390/ph16070970 |